Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Yuanta Biotechnology is a prominent Chinese manufacturer specializing in the production of amino acids and fine chemical intermediates. As a subsidiary of China Grand Pharmaceutical and Healthcare Holdings, the company operates one of the largest glycine production facilities globally, serving the pharmaceutical, food, and feed industries. Their product portfolio includes pharmaceutical-grade glycine, L-alanine, and other amino acid derivatives produced through advanced fermentation and synthesis processes. The company maintains international quality certifications, including GMP and ISO, to support its role as a key supplier in the global life sciences supply chain. Its operations are centered in the Wuji County industrial zone of Shijiazhuang, leveraging large-scale production capabilities to meet international demand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Yuanta Biotechnology.